BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11593149)

  • 21. Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole.
    Fontaine C; Bousquet PJ; Demoly P
    J Allergy Clin Immunol; 2005 Mar; 115(3):633-4. PubMed ID: 15753917
    [No Abstract]   [Full Text] [Related]  

  • 22. Exacerbation of inflammatory bowel disease associated with use of celecoxib.
    Bonner GF
    Am J Gastroenterol; 2001 Apr; 96(4):1306-8. PubMed ID: 11316199
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety of celecoxib in patients with adverse reactions to nimesulide.
    Liccardi G; D'Amato G; Canonica GW; Lobefalo G; Noschese P; Piccolo A; Salzillo A; Passalacqua G
    Allergy; 2005 May; 60(5):708-9. PubMed ID: 15813826
    [No Abstract]   [Full Text] [Related]  

  • 24. [Nephrotic syndrome associated to celecoxib].
    Sirvent AE; Enríquez R; Amorós F; Reyes A
    Nefrologia; 2005; 25(1):81-2. PubMed ID: 15789542
    [No Abstract]   [Full Text] [Related]  

  • 25. A case report of allergy to exenatide.
    Pérez E; Martínez-Tadeo J; Callero A; Hernández G; Rodríguez-Plata E; García-Robaina JC
    J Allergy Clin Immunol Pract; 2014; 2(6):822-3. PubMed ID: 25439386
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hyperkalemia and celecoxib].
    Rego MJ; Fonseré N; Martí S; Rey-Joly C
    Med Clin (Barc); 2002 Jun; 119(1):36-7. PubMed ID: 12062005
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lower gastrointestinal hemorrhage associated with celecoxib].
    Serrano Pozo A; Jara Palomares L; Fuentes Rodríguez F; Calderón Sandubete E
    An Med Interna; 2003 Sep; 20(9):497. PubMed ID: 14755912
    [No Abstract]   [Full Text] [Related]  

  • 28. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
    Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
    Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
    Wolfe F; Zhao S; Pettitt D
    J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Severe cutaneous drug reactions to celecoxib (Celebrex)].
    Marquès S; Milpied B; Foulc P; Barbarot S; Cassagnau E; Stalder JF
    Ann Dermatol Venereol; 2003 Nov; 130(11):1051-5. PubMed ID: 14724542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aseptic meningitis possibly associated with celecoxib.
    Papaioannides DH; Korantzopoulos PG; Giotis CH
    Ann Pharmacother; 2004 Jan; 38(1):172. PubMed ID: 14742817
    [No Abstract]   [Full Text] [Related]  

  • 33. Celecoxib and CVS risk--lessons from the APC and PreSAP studies.
    Armstrong DJ
    Rheumatology (Oxford); 2007 Apr; 46(4):561-2. PubMed ID: 17132690
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
    Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
    Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaphylaxis to celecoxib.
    Grob M; Pichler WJ; Wüthrich B
    Allergy; 2002 Mar; 57(3):264-5. PubMed ID: 11906348
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis.
    Suárez-Otero R; Robles-San Román M; Jaimes-Hernández J; Oropeza-De La Madrid E; Medina-Peñaloza RM; Rosas-Ramos R; Castañeda-Hernández G
    Proc West Pharmacol Soc; 2002; 45():26-8. PubMed ID: 12434517
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety of short-term administration of celecoxib in decompensated cirrhosis.
    Campbell MS; Makar GA
    Hepatology; 2005 Jul; 42(1):237; author reply 238. PubMed ID: 15892075
    [No Abstract]   [Full Text] [Related]  

  • 38. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and management of drug-induced anaphylaxis].
    Horikawa T
    Arerugi; 2007 Jul; 56(7):655-61. PubMed ID: 17671407
    [No Abstract]   [Full Text] [Related]  

  • 40. Erectile dysfunction induced probably by celecoxib.
    Dhikav V; Gupta S; Anand KS
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):211-2. PubMed ID: 18236511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.